A new molecular target of insulin action: regulating the pivotal PDK1.

Current drug targets. Immune, endocrine and metabolic disorders

Volumn 1, Issue 3, 2001, Pages 209-221

  Wick, K L ^a   Liu, F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; GLUCOSE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL; CELL FRACTIONATION; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; PHOSPHORYLATION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL SURVIVAL; CLONING, MOLECULAR; ENZYME INHIBITORS; GLUCOSE; HUMANS; INSULIN; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

MLCS; MLOWN;

EID: 0035502498     PISSN: 15680088     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568008013341082     Document Type: Review

References (113)